";s:4:"text";s:3688:" (PDF/67.55 KB) The company also carried out a study that showed that it is ‘bioequivalent’ to the reference medicine. (PDF/23.81 KB) Take bictegravir, emtricitabine, and tenofovir exactly as directed. Pregnancy and breastfeeding. (PDF/68.32 KB) (PDF/414.07 KB) In the United States, it is recommend that all pregnant HIV-infected women start antiretroviral therapy (ART) as early in pregnancy as possible to reduce risk of transmission. Emtricitabine/tenofovir may also be considered for some antiviral resistant hepatitis B infections. (PDF/754.83 KB) (PDF/732.9 KB) (PDF/87.8 KB) Common side effects include headache, tiredness, trouble sleeping, abdominal pain, weight loss, and rash.Emtricitabine/tenofovir was approved for medical use in the United States in 2004.Emtricitabine/tenofovir is used both to treat and to prevent HIV/AIDS.The Centers for Disease Control and Prevention (CDC) recommends the use of emtricitabine/tenofovir for The CDC recommends PrEP be considered for the following high-risk groups:The consideration of utilizing emtricitabine/tenofovir as a reduction strategy involves discussion with a health professional who can help the patient navigate the benefits and risks. (PDF/725.1 KB) (PDF/765.97 KB) Truvada, which contains 200 mg emtricitabine and 245 mg tenofovir disoproxil (equivalent to 300 mg tenofovir disoproxil fumarate or 136 mg of tenofovir) in each film-coated tablet, is intended for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. (PDF/28.96 KB) (PDF/68.97 KB) (PDF/78.88 KB) This disorder occurs in 1.7% of patients. (PDF/51.48 KB) (PDF/797.51 KB)